Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 12
2022 29
2023 17
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Fahed G, et al. Among authors: bou zerdan m. Int J Mol Sci. 2022 Jan 12;23(2):786. doi: 10.3390/ijms23020786. Int J Mol Sci. 2022. PMID: 35054972 Free PMC article. Review.
Systemic AL amyloidosis: current approach and future direction.
Bou Zerdan M, Nasr L, Khalid F, Allam S, Bouferraa Y, Batool S, Tayyeb M, Adroja S, Mammadii M, Anwer F, Raza S, Chaulagain CP. Bou Zerdan M, et al. Oncotarget. 2023 Apr 26;14:384-394. doi: 10.18632/oncotarget.28415. Oncotarget. 2023. PMID: 37185672 Free PMC article. Review.
Neurobrucellosis: Brief Review.
Bouferraa Y, Bou Zerdan M, Hamouche R, Azar E, Afif C, Jabbour R. Bouferraa Y, et al. Among authors: bou zerdan m. Neurologist. 2021 Nov 4;26(6):248-252. doi: 10.1097/NRL.0000000000000348. Neurologist. 2021. PMID: 34734902 Review.
Drug-Induced Peripheral Neuropathy: Diagnosis and Management.
Merheb D, Dib G, Zerdan MB, Nakib CE, Alame S, Assi HI. Merheb D, et al. Among authors: zerdan mb. Curr Cancer Drug Targets. 2022;22(1):49-76. doi: 10.2174/1568009621666210720142542. Curr Cancer Drug Targets. 2022. PMID: 34288840 Review.
Mechanisms of Immunotoxicity: Stressors and Evaluators.
Bou Zerdan M, Moussa S, Atoui A, Assi HI. Bou Zerdan M, et al. Int J Mol Sci. 2021 Jul 31;22(15):8242. doi: 10.3390/ijms22158242. Int J Mol Sci. 2021. PMID: 34361007 Free PMC article. Review.
Oligodendroglioma: A Review of Management and Pathways.
Bou Zerdan M, Assi HI. Bou Zerdan M, et al. Front Mol Neurosci. 2021 Oct 5;14:722396. doi: 10.3389/fnmol.2021.722396. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34675774 Free PMC article. Review.
Radioimmunoconjugates in the age of modern immuno-oncology.
Nasr D, Kumar PA, Zerdan MB, Ghelani G, Dutta D, Graziano S, Lim SH. Nasr D, et al. Among authors: zerdan mb. Life Sci. 2022 Dec 1;310:121126. doi: 10.1016/j.lfs.2022.121126. Epub 2022 Oct 27. Life Sci. 2022. PMID: 36309222 Review.
Carbapenemase Inhibitors: Updates on Developments in 2021.
Bou Zerdan M, Al Hassan S, Shaker W, El Hajjar R, Allam S, Bou Zerdan M, Naji A, Zeineddine N. Bou Zerdan M, et al. J Clin Med Res. 2022 Jul;14(7):251-259. doi: 10.14740/jocmr4764. Epub 2022 Jul 29. J Clin Med Res. 2022. PMID: 35974805 Free PMC article. Review.
Liquid biopsies and minimal residual disease in myeloid malignancies.
Allam S, Nasr K, Khalid F, Shah Z, Khan Suheb MZ, Mulla S, Vikash S, Bou Zerdan M, Anwer F, Chaulagain CP. Allam S, et al. Among authors: bou zerdan m. Front Oncol. 2023 May 5;13:1164017. doi: 10.3389/fonc.2023.1164017. eCollection 2023. Front Oncol. 2023. PMID: 37213280 Free PMC article. Review.
55 results